UnitedHealth Group is a top dividend growth stock with strong financials and potential for 20%+ returns by 2026. Read more ...

UnitedHealth has used algorithms to limit mental health coverage, denying necessary therapy and forcing patients to pay ...

Analyst Erin Wright of Morgan Stanley maintained a Buy rating on UnitedHealth (UNH – Research Report), retaining the price target of ...

UnitedHealth Group will host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024, beginning at 8:00 a.m. EST.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.23% of ...

A conservative federal judge in Texas has ruled in favor of UnitedHealth Group over Medicare Advantage star ratings.

UnitedHealthcare overcomes challenges for long-term success, targets 13-16% earnings growth, presents buying opportunity with $700 price target by 2025.

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter ...

Mairs & Power, an investment advisor, released the “Mairs & Power Growth Fund” third quarter 2024 investor letter. A copy of ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

The U.S. Department of Justice (DOJ) and four state attorneys general filed a lawsuit to block UnitedHealth Group’s (NYSE: ...

UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market capitalization of $543.67 billion, a P/E ratio of 38.49, a price-to-earnings-growth ratio of 1 ...